Comparison
Why is Cardiol Therapeutics, Inc. ?
Unrated Stock - No Analysis Available
Quality key factors
Factor
Value
Sales Growth (5y)
0
EBIT Growth (5y)
-187.93%
EBIT to Interest (avg)
-30.49
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-1.32
Sales to Capital Employed (avg)
0.00
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
11.55%
ROCE (avg)
0
ROE (avg)
0
Valuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
16.94
EV to EBIT
-4.14
EV to EBITDA
-4.16
EV to Capital Employed
-74.26
EV to Sales
NA
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
-363.86%
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Sideways
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
No Trend
Mildly Bullish
Technical Movement
7What is working for the Company
OPERATING CASH FLOW(Y)
Highest at CAD -24.22 MM
NET PROFIT(HY)
Higher at CAD -18.32 MM
RAW MATERIAL COST(Y)
Fallen by 0% (YoY
-3What is not working for the Company
ROCE(HY)
Lowest at -347.98%
CASH AND EQV(HY)
Lowest at CAD 29.82 MM
Here's what is working for Cardiol Therapeutics, Inc.
Operating Cash Flow
Highest at CAD -24.22 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (CAD MM)
Net Profit
Higher at CAD -18.32 MM
than preceding 12 month period ended Sep 2025MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months
Net Profit (CAD MM)
Raw Material Cost
Fallen by 0% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Cardiol Therapeutics, Inc.
Cash and Eqv
Lowest at CAD 29.82 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents






